Kristy L. Kolc
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Corrigendum to "Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy" [Epilepsy Res. (2023) 191 107112].
Journal: Epilepsy research
Published: March 13, 2024
Measuring psychiatric symptoms online: A systematic review of the use of inventories on Amazon Mechanical Turk (mTurk).
Journal: Journal of psychiatric research
Published: December 07, 2022
Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy.
Journal: Epilepsy research
Published: November 17, 2022
PCDH19 Pathogenic Variants in Males: Expanding the Phenotypic Spectrum.
Journal: Advances in experimental medicine and biology
Published: August 28, 2020
Levetiracetam efficacy in PCDH19 Girls Clustering Epilepsy.
Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
Published: December 01, 2019
A standardized patient-centered characterization of the phenotypic spectrum of PCDH19 girls clustering epilepsy.
Journal: Translational psychiatry
Published: October 21, 2019
Integrated in silico and experimental assessment of disease relevance of PCDH19 missense variants.
Journal: Human mutation
Published: October 11, 2019
A systematic review and meta-analysis of 271 PCDH19-variant individuals identifies psychiatric comorbidities, and association of seizure onset and disease severity.
Journal: Molecular psychiatry
Published: September 12, 2017
Protocadherin 19 (PCDH19) interacts with paraspeckle protein NONO to co-regulate gene expression with estrogen receptor alpha (ERα).
Journal: Human molecular genetics
Published: October 11, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026